Skip to content

Bull Bear Daily

Home
Business
Domestic
Economy
Money
Politics
Top News
Newsletters

Search for:

Home
2023
December
26
Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push
A sign stands outside a Bristol Myers Squibb facility in

A sign stands outside a Bristol Myers Squibb facility in

FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo

Post navigation

Previous: Bristol Myers to buy RayzeBio for $4.1 billion in targeted cancer therapy push

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Sign up for our free Bull Bear Daily Newsletter!

Discover new market trends and ideas directly to your inbox.

Search

Recent Posts

US FDA investigates Takeda’s blood disorder drug after pediatric death
New Orleans is the next target of Trump immigration crackdown, sources say
Fed’s Collins: Monetary policy currently in right place, hesitant about cutting rates
New Orleans is the next target of Trump immigration crackdown, sources say
Airbus signs 150-jet deal with flydubai worth $24 billion

You may have missed

2025-11-21T213811Z_3_LYNXMPELAK0XZ_RTROPTP_4_TAKEDA-PHARMA-HEALTH.JPG

Newsletters

US FDA investigates Takeda’s blood disorder drug after pediatric death

Bull Bear Daily November 23, 2025 0

Newsletters

New Orleans is the next target of Trump immigration crackdown, sources say

Bull Bear Daily November 22, 2025 0

2025-11-22T141110Z_1_LYNXMPELAL08K_RTROPTP_4_USA-FED-JACKSON-HOLE-COLLINS

Uncategorized

Fed’s Collins: Monetary policy currently in right place, hesitant about cutting rates

Bull Bear Daily November 22, 2025 0

2025-11-22T011516Z_1_LYNXMPELAL00Q_RTROPTP_4_USA-TRUMP-NEW-ORLEANS

Uncategorized

New Orleans is the next target of Trump immigration crackdown, sources say

Bull Bear Daily November 22, 2025 0

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us

Home
Privacy Policy
Terms of Service
Disclaimer
Contact Us

Copyright 2025 © All rights reserved | Bull Bear Daily | bullbeardaily.com